Protection of blue shrimp (Litopenaeus stylirostris) against the White Spot Syndrome Virus (WSSV) when injected with shrimp lysozyme.
In this study we found that a blue shrimp (Litopenaeus stylirostris) lysozyme gene (Lslzm) was up-regulated in WSSV-infected shrimp, suggesting that lysozyme is involved in the innate response of shrimp to this virus. Shrimp were intramuscularly injected with Lslzm protein to identify how this recombinant protein protects L. stylirostris from WSSV infection and to determine how this protein influences nonspecific cellular and humoral defense mechanisms. Higher survival rates and a lower viral load (compared with controls) were reported for shrimps that were first injected with the Lslzm protein and then infected with WSSV. In addition, the Lslzm expression level and the immunological parameters (including THC, phagocytic activity, respiratory burst activity, phenoloxidase activity and lysozyme activity) were all significantly higher in the WSSV-infected shrimp treated with the Lslzm protein, compared with the controls. These results indicate that lysozyme is effective at blocking WSSV infection in L. stylirostris and that lysozyme modulates the cellular and humoral defense mechanisms after they are suppressed by the WSSV virus.
Mai
Wei-jun
WJ
Key Laboratory of Ecology and Environment Science in Guangdong Higher Education, Guangdong Provincial Key Laboratory for Healthy and Safe Aquaculture, College of Life Science, South China Normal University, Guangzhou 510631, China. mwj9876@yahoo.com.cn
Wang
Wei-na
WN
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D020869:Gene Expression Profiling; D015971:Gene Expression Regulation, Enzymologic; D007113:Immunity, Innate; D009113:Muramidase / Q000276:immunology*; D033561:Penaeidae / Q000821:virology*; D011994:Recombinant Proteins / Q000494:pharmacology; D013997:Time Factors; D015854:Up-Regulation; D019562:Viral Load; D016662:Virus Integration / Q000187:drug effects; D046848:White spot syndrome virus 1 / Q000502:physiology*
D000998:Antiviral Agents; D011994:Recombinant Proteins; D009113:Muramidase